James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 47,525 shares at $64.98 ($3.1M) on 2018-10-08, disclosed to the SEC on 2018-10-10.
Scheduled sale ($3.1M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.98 | 16,215 | $1.1M | 34.2% |
| 2 | $65.82 | 6,310 | $415K | 13.5% |
| 3 | $64.23 | 19,270 | $1.2M | 40.2% |
| 4 | $64.86 | 5,730 | $372K | 12.1% |
| Total | $64.77 avg | 47,525 | $3.1M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |